Total Payments
$24,781
2024 Payments
$2,949
Companies
26
Transactions
285
Medicare Patients
11,199
Medicare Billing
$265,385
Payment Breakdown by Category
Other$14,775 (59.6%)
Food & Beverage$6,886 (27.8%)
Travel$3,045 (12.3%)
Education$74.18 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,775 | 3 | 59.6% |
| Food and Beverage | $6,886 | 266 | 27.8% |
| Travel and Lodging | $3,045 | 11 | 12.3% |
| Education | $74.18 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $17,454 | 18 | $0 (2024) |
| Medtronic, Inc. | $1,693 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,211 | 87 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $720.22 | 37 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $503.33 | 19 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $411.28 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $395.50 | 21 | $0 (2024) |
| PFIZER INC. | $371.88 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $308.13 | 10 | $0 (2020) |
| Amgen Inc. | $285.87 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,949 | 44 | Medtronic, Inc. ($1,674) |
| 2023 | $696.00 | 33 | Merck Sharp & Dohme LLC ($166.48) |
| 2022 | $634.10 | 26 | AstraZeneca Pharmaceuticals LP ($170.89) |
| 2021 | $464.16 | 27 | AstraZeneca Pharmaceuticals LP ($90.48) |
| 2020 | $294.41 | 13 | Novartis Pharmaceuticals Corporation ($55.82) |
| 2019 | $675.46 | 37 | E.R. Squibb & Sons, L.L.C. ($165.03) |
| 2018 | $18,105 | 53 | Novo Nordisk Inc ($17,273) |
| 2017 | $962.77 | 52 | Novartis Pharmaceuticals Corporation ($289.83) |
All Payment Transactions
285 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $279.00 | General |
| 11/25/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $44.50 | General |
| 11/22/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $391.14 | General |
| 11/22/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $281.53 | General |
| 11/22/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $215.72 | General |
| 11/22/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $156.28 | General |
| 11/22/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $3.41 | General |
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $302.84 | General |
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/07/2024 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/22/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $111.90 | General |
| 07/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.64 | General |
| Category: Cardiovascular | ||||||
| 07/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $3.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 3,484 | 4,116 | $163,152 | $62,040 |
| 2022 | 16 | 2,602 | 2,878 | $148,509 | $70,368 |
| 2021 | 16 | 2,427 | 2,704 | $167,459 | $72,595 |
| 2020 | 14 | 2,686 | 3,121 | $284,386 | $60,382 |
Total Patients
11,199
Total Services
12,819
Medicare Billing
$265,385
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 2,484 | 3,055 | $61,100 | $17,616 | 28.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 184 | 185 | $20,700 | $8,690 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 107 | 128 | $12,416 | $8,531 | 68.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 118 | $12,056 | $7,437 | 61.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 62 | 62 | $9,959 | $5,325 | 53.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 30 | 37 | $5,328 | $3,683 | 69.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 20 | $2,880 | $2,140 | 74.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 33 | 33 | $15,984 | $1,842 | 11.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 127 | 146 | $4,426 | $1,521 | 34.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 33 | 33 | $3,476 | $1,496 | 43.0% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 22 | 22 | $6,752 | $1,123 | 16.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 63 | 63 | $2,778 | $988.20 | 35.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 144 | 150 | $3,000 | $852.53 | 28.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 12 | 13 | $568.00 | $252.85 | 44.5% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 14 | 14 | $744.00 | $239.07 | 32.1% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 13 | 13 | $702.00 | $208.34 | 29.7% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 11 | 12 | $172.00 | $67.56 | 39.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 11 | 12 | $111.00 | $28.68 | 25.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 327 | 329 | $28,623 | $17,279 | 60.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,486 | 1,696 | $33,920 | $10,047 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 105 | 113 | $11,265 | $7,639 | 67.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 109 | $10,404 | $7,243 | 69.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 63 | 63 | $10,405 | $6,576 | 63.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 44 | 49 | $6,908 | $5,006 | 72.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 32 | 58 | $6,322 | $3,276 | 51.8% |
About Dr. Daniel Friedman, MD
Dr. Daniel Friedman, MD is a Cardiovascular Disease healthcare provider based in Albuquerque, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992899363.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Friedman, MD has received a total of $24,781 in payments from pharmaceutical and medical device companies, with $2,949 received in 2024. These payments were reported across 285 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,775).
As a Medicare-enrolled provider, Friedman has provided services to 11,199 Medicare beneficiaries, totaling 12,819 services with total Medicare billing of $265,385. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Albuquerque, NM
- Active Since 10/03/2006
- Last Updated 10/25/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1992899363
Products in Payments
- Ozempic (Drug) $6,298
- ENTRESTO (Drug) $992.06
- ELIQUIS (Drug) $784.57
- XARELTO (Drug) $678.60
- LifeVest (Device) $411.28
- JARDIANCE (Drug) $274.61
- HYPERLIPIDEMIA - DISEASE (Drug) $252.70
- LEQVIO (Drug) $219.23
- FARXIGA (Drug) $185.98
- BRILINTA (Drug) $171.54
- Repatha (Biological) $151.21
- CAMZYOS (Drug) $145.84
- Corlanor (Drug) $134.66
- WATCHMAN Access System (Device) $75.29
- VERQUVO (Drug) $53.09
- XEOMIN (Biological) $50.24
- LUTONIX (Device) $48.97
- Vascepa (Drug) $42.67
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM (Device) $38.67
- PRADAXA (Drug) $33.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Albuquerque
Dr. Mark Bieniarz, Md, MD
Cardiovascular Disease — Payments: $247,387
Cardiovascular Disease $247,387
Abinash Achrekar
Cardiovascular Disease — Payments: $181,216
Cardiovascular Disease $181,216
Dr. Michael Hoskins, M.d, M.D
Cardiovascular Disease — Payments: $79,188
Cardiovascular Disease $79,188
Dr. Geoffrey Kunz, Md, MD
Cardiovascular Disease — Payments: $21,282
Cardiovascular Disease $21,282
Dr. Charles Kim, Md, MD
Cardiovascular Disease — Payments: $10,645
Cardiovascular Disease $10,645
Warren Laskey, Md, MD
Cardiovascular Disease — Payments: $10,417
Cardiovascular Disease $10,417